Market Capitalization of Fredun Pharmaceuticals (FREDUN)
As of Sept. 18, 2026, Fredun Pharmaceuticals (FREDUN) market capitalisation is ₹2247.03 Cr ($249.67M), with 1.72 Cr shares outstanding at a current price of ₹1303.50 on NSE, ranking 1148 out of 5367 companies by market cap in our screener. Fredun Pharmaceuticals operates in the Healthcare sector and is classified as a Small Cap stock. View FREDUN annual price range for the annual high/low range and current price position.
Market Cap History of Fredun Pharmaceuticals (Last 10 Years)
FREDUN market capitalisation from year-end NSE closing prices over the last 10 years. Explore FREDUN value investing to estimate fundamental worth using multiple valuation models.
End of Year Market Cap History — Fredun Pharmaceuticals
FREDUN year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see Fredun Pharmaceuticals screener.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹2247.03 Cr
$249.67M USD
|
₹1303.50 | NSE | -17.41% |
| 2025 |
₹2720.74 Cr
$302.30M USD
|
₹1578.30 | BSE | +114.08% |
| 2024 |
₹1270.90 Cr
$141.21M USD
|
₹737.25 | BSE | -15.14% |
| 2023 |
₹1497.59 Cr
$166.40M USD
|
₹868.75 | BSE | -22.45% |
| 2022 |
₹1931.05 Cr
$214.56M USD
|
₹1120.20 | BSE | +32.45% |
| 2021 |
₹1457.94 Cr
$161.99M USD
|
₹845.75 | BSE | +95.21% |
| 2020 |
₹746.86 Cr
$82.98M USD
|
₹433.25 | BSE | +92.30% |
| 2019 |
₹388.38 Cr
$43.15M USD
|
₹225.30 | BSE | -33.17% |
| 2018 |
₹581.11 Cr
$64.57M USD
|
₹337.10 | BSE | +223.20% |
| 2017 |
₹179.80 Cr
$19.98M USD
|
₹104.30 | BSE | +125.51% |
| 2016 |
₹79.73 Cr
$8.86M USD
|
₹46.25 | BSE | - |